Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

Centre Hospitalier Universitaire Dijon19 enrolled

Overview

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

Study Type

OBSERVATIONAL

Enrollment

Conditions

Abdominal Aortic Aneurysm

Interventions

Type II endoleak treatmentPROCEDURE

Type II endoleak endovascular treatment

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients treated for type II endoleaks by endovascular therapy Exclusion Criteria: * None

Locations (1)

Cardiovascular and thoracic surgery unit, CHU Dijon

Dijon, France

Outcomes

Primary Outcomes

Recurrence rate of type II endoleaks treated with endovascular intervention

Time frame: 12 years

Secondary Outcomes

Type of type II endoleaks treatment

Time frame: 12 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.